ID

28286

Description

Bispecific Antibody in Finding Tumor Cells in Patients With Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00895323

Link

https://clinicaltrials.gov/show/NCT00895323

Keywords

  1. 1/2/18 1/2/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

January 2, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Colorectal Cancer NCT00895323

Eligibility Colorectal Cancer NCT00895323

Criteria
Description

Criteria

histologically confirmed colorectal cancer
Description

Colorectal Carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C0009402
radiological documentation of disease is preferred, but not required
Description

Disease Documentation Radiologic

Data type

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0920316
UMLS CUI [1,3]
C0205483
patient characteristics:
Description

Client Characteristics

Data type

boolean

Alias
UMLS CUI [1]
C0815172
karnofsky performance status 70-100%
Description

Karnofsky Performance Status

Data type

boolean

Alias
UMLS CUI [1]
C0206065
life expectancy ≥ 3 months
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
wbc ≥ 3,000/mm³
Description

White Blood Cell Count procedure

Data type

boolean

Alias
UMLS CUI [1]
C0023508
neutrophil count ≥ 1,500/mm³
Description

Neutrophil count

Data type

boolean

Alias
UMLS CUI [1]
C0200633
platelet count ≥ 100,000/mm³
Description

Platelet Count measurement

Data type

boolean

Alias
UMLS CUI [1]
C0032181
serum creatinine normal
Description

Serum creatinine normal

Data type

boolean

Alias
UMLS CUI [1]
C0438244
bilirubin ≤ 1.5 times upper limit of normal (uln)
Description

Serum total bilirubin measurement

Data type

boolean

Alias
UMLS CUI [1]
C1278039
ast/alt < 2 times uln
Description

Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Data type

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C0201836
not pregnant or nursing
Description

Exclusion Criteria | Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C0032961
UMLS CUI [3]
C0006147
fertile patients must use effective contraception during and for 1 month after completion of study therapy
Description

Fertility Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1,1]
C0015895
UMLS CUI [1,2]
C0700589
no medical conditions that might prevent full participation in protocol-required testing or follow-up
Description

Exclusion | Medical condition Preventing Protocol Compliance

Data type

boolean

Alias
UMLS CUI [1]
C2828389
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C1292733
UMLS CUI [2,3]
C0525058
no institutionalized patients (e.g., in prisons or mental health institutions)
Description

Exclusion Criteria | Institutionalized Persons | Prisoners

Data type

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C0376326
UMLS CUI [3]
C0033167
prior concurrent therapy:
Description

Therapeutic procedure

Data type

boolean

Alias
UMLS CUI [1]
C0087111
no concurrent chemotherapy or treatments that would compromise the safety and efficacy of protocol assessments
Description

Exclusion Criteria | Chemotherapy compromises Protocol Assessment | Therapeutic procedure compromises Protocol Assessment

Data type

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C2945640
UMLS CUI [2,3]
C2348563
UMLS CUI [2,4]
C1516048
UMLS CUI [3,1]
C0087111
UMLS CUI [3,2]
C2945640
UMLS CUI [3,3]
C2348563
UMLS CUI [3,4]
C1516048

Similar models

Eligibility Colorectal Cancer NCT00895323

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Colorectal Carcinoma
Item
histologically confirmed colorectal cancer
boolean
C0009402 (UMLS CUI [1])
Disease Documentation Radiologic
Item
radiological documentation of disease is preferred, but not required
boolean
C0012634 (UMLS CUI [1,1])
C0920316 (UMLS CUI [1,2])
C0205483 (UMLS CUI [1,3])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Karnofsky Performance Status
Item
karnofsky performance status 70-100%
boolean
C0206065 (UMLS CUI [1])
Life Expectancy
Item
life expectancy ≥ 3 months
boolean
C0023671 (UMLS CUI [1])
White Blood Cell Count procedure
Item
wbc ≥ 3,000/mm³
boolean
C0023508 (UMLS CUI [1])
Neutrophil count
Item
neutrophil count ≥ 1,500/mm³
boolean
C0200633 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count ≥ 100,000/mm³
boolean
C0032181 (UMLS CUI [1])
Serum creatinine normal
Item
serum creatinine normal
boolean
C0438244 (UMLS CUI [1])
Serum total bilirubin measurement
Item
bilirubin ≤ 1.5 times upper limit of normal (uln)
boolean
C1278039 (UMLS CUI [1])
Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
ast/alt < 2 times uln
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
Exclusion Criteria | Pregnancy | Breast Feeding
Item
not pregnant or nursing
boolean
C0680251 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
Fertility Contraceptive methods
Item
fertile patients must use effective contraception during and for 1 month after completion of study therapy
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Exclusion | Medical condition Preventing Protocol Compliance
Item
no medical conditions that might prevent full participation in protocol-required testing or follow-up
boolean
C2828389 (UMLS CUI [1])
C3843040 (UMLS CUI [2,1])
C1292733 (UMLS CUI [2,2])
C0525058 (UMLS CUI [2,3])
Exclusion Criteria | Institutionalized Persons | Prisoners
Item
no institutionalized patients (e.g., in prisons or mental health institutions)
boolean
C0680251 (UMLS CUI [1])
C0376326 (UMLS CUI [2])
C0033167 (UMLS CUI [3])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
Exclusion Criteria | Chemotherapy compromises Protocol Assessment | Therapeutic procedure compromises Protocol Assessment
Item
no concurrent chemotherapy or treatments that would compromise the safety and efficacy of protocol assessments
boolean
C0680251 (UMLS CUI [1])
C0392920 (UMLS CUI [2,1])
C2945640 (UMLS CUI [2,2])
C2348563 (UMLS CUI [2,3])
C1516048 (UMLS CUI [2,4])
C0087111 (UMLS CUI [3,1])
C2945640 (UMLS CUI [3,2])
C2348563 (UMLS CUI [3,3])
C1516048 (UMLS CUI [3,4])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial